Pasar al contenido principal

BASES MOLECULARES Y CELULARES DE ENFERMEDADES RARAS ASOCIADAS A AUTOFAGIA

PID2021-127355OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effect of rapamycin on lysosomal accumulation in a CRISPR/Cas9-based cellular model of VPS13A deficiency

  • Tornero-Écija, Alba
  • Navas, María-Angeles
  • Muñoz-Braceras, Sandra
  • Vincent, Olivier
  • Escalante, Ricardo
VPS13A is a lipid transfer protein localized at different membrane contact sites between organelles, and mutations in the corresponding gene produce a rare neurodegenerative disease called chorea-acanthocytosis (ChAc). Previous studies showed that VPS13A depletion in HeLa cells results in an accumulation of endosomal and lysosomal markers, suggesting a defect in lysosomal degradation capacity leading to partial autophagic dysfunction. Our goal was to determine whether compounds that modulate the endo-lysosomal pathway could be beneficial in the treatment of ChAc. To test this hypothesis, we first generated a KO model using CRISPR/Cas9 to study the consequences of the absence of VPS13A in HeLa cells. We found that inactivation of VPS13A impairs cell growth, which precludes the use of isolated clones due to the undesirable selection of edited clones with residual protein expression. Therefore, we optimized the use of pool cells obtained shortly after transfection with CRISPR/Cas9 components. These cells are a mixture of wild-type and edited cells that allow a comparative analysis of phenotypes and avoids the selection of clones with residual level of VPS13A expression after long-term growth. Consistent with previous observations by siRNA inactivation, VPS13A inactivation by CRISPR/Cas9 resulted in accumulation of the endo-lysosomal markers RAB7A and LAMP1. Notably, we observed that rapamycin partially suppressed the difference in lysosome accumulation between VPS13A KO and WT cells, suggesting that modulation of the autophagic and lysosomal pathway could be a therapeutic target in the treatment of ChAc., This work has been supported by the ‘Ministerio de Ciencia e Innovación’, grants numbers PGC2018-093604-B-I00 (MICINN/AEI/FEDER, UE), PID2021-127355OB-I00 (MICIN/AEI/10.13039/501100011033/FEDER Una manera de hacer Europa). A.T. has been supported by Garantía Juvenil Program from Comunidad de Madrid and Advocacy for Neuroacanthocytosis patients (INT-GB/0775)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The association of lipid transfer protein VPS13A with endosomes is mediated by sorting nexin SNX5

  • Tornero-Écija, Alba
  • Zapata-Del-Baño, Antonia
  • Antón-Esteban, Laura
  • Vincent, Olivier
  • Escalante, Ricardo
Human VPS13 proteins are implicated in severe neurological diseases. These proteins play an important role in lipid transport at membrane contact sites between different organelles. Identification of adaptors that regulate the subcellular localization of these proteins at specific membrane contact sites is essential to understand their function and role in disease. We have identified the sorting nexin SNX5 as an interactor of VPS13A that mediates its association with endosomal subdomains. As for the yeast sorting nexin and Vps13 endosomal adaptor Ypt35, this association involves the VPS13 adaptor-binding (VAB) domain in VPS13A and a PxP motif in SNX5. Notably, this interaction is impaired by mutation of a conserved asparagine residue in the VAB domain, which is also required for Vps13-adaptor binding in yeast and is pathogenic in VPS13D. VPS13A fragments containing the VAB domain co-localize with SNX5, whereas the more C-terminal part of VPS13A directs its localization to the mitochondria. Overall, our results suggest that a fraction of VPS13A localizes to junctions between the endoplasmic reticulum, mitochondria, and SNX5-containing endosomes., This work has been supported by the “Ministerio de Ciencia, Innovación y Universidades” PGC2018-093604-B-I00 (MCIU/AEI/FEDER, UE) and "Ministerio de Ciencia e Innovación" PID2021-127355OB-I00 (MCIN/AEI/10.13039/501100011033/FEDER, Una manera de hacer Europa). A Tornero-Écija has been supported by the Garantía Juvenil Program from Comunidad de Madrid and Advocacy for Neuroacanthocytosis Patients. We thank Celia Cruz-Cuevas for technical assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Coiled-coil-mediated dimerization of Atg16 is required for binding to the PROPPIN Atg21

  • Bueno-Arribas, Miranda
  • Cruz-Cuevas, Celia
  • Navas, María-Angeles
  • Escalante, Ricardo
  • Vincent, Olivier
PROPPINs/WIPIs are β-propeller proteins that bind phosphoinositides and contribute to the recruitment of protein complexes involved in membrane remodelling processes such as autophagosome formation and endosomal trafficking. Yeast Atg21 and mammalian WIPI2 interact with Atg16/ATG16L1 to mediate recruitment of the lipidation machinery to the autophagosomal membrane. Here, we used the reverse double two-hybrid method (RD2H) to identify residues in Atg21 and Atg16 critical for protein-protein binding. Although our results are generally consistent with the crystal structure of the Atg21-Atg16 complex reported previously, they also reveal that dimerization of the Atg16 coiled-coil domain is required for Atg21 binding. Furthermore, most of the residues identified in Atg21 are conserved in WIPI2 and we showed that these residues also mediate ATG16L1 binding. Strikingly, these residues occupy the same position in the β-propeller structure as residues in PROPPINs/WIPIs Hsv2 and WIPI4 that mediate Atg2/ATG2A binding, supporting the idea that these proteins use different amino acids at the same position to interact with different autophagic proteins. Finally, our findings demonstrate the effectiveness of the RD2H system to identify critical residues for protein-protein interactions and the utility of this method to generate combinatory mutants with a complete loss of binding capacity., This work has been supported by grants PGC2018-093604-B-I00 (MCIU/AEI/FEDER, UE) and PID2021-127355OB-I00 (MCIN/AEI/10.13039/501100011033/FEDER, Una manera de hacer Europa). M.B.-A. has been supported by a fellowship from the Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ and C.C.-C. has been supported by the Garantía Juvenil Program from Comunidad de Madrid., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A burning question from the first international BPAN symposium: is restoration of autophagy a promising therapeutic strategy for BPAN?

  • Mollereau, Bertrand
  • Hayflick, Susan J.
  • Escalante, Ricardo
  • Mauthe, Mario
  • Papandreou, Apostolos
  • Luso, Arcangela
  • Celle, Marion
  • Aniorte, Sahra
  • Raouf Issa, Abdul
  • Lasserre, Jean Paul
  • Lesca, Gaetan
  • Thobois, Stéphane
  • Burger, Pauline
© 2023 Informa UK Limited, trading as Taylor & Francis Group., Beta-propeller protein-associated neurodegeneration (BPAN) is a rare neurodegenerative disease associated with severe cognitive and motor deficits. BPAN pathophysiology and phenotypic spectrum are still emerging due to the fact that mutations in the WDR45 (WD repeat domain 45) gene, a regulator of macroautophagy/autophagy, were only identified a decade ago. In the first international symposium dedicated to BPAN, which was held in Lyon, France, a panel of international speakers, including several researchers from the autophagy community, presented their work on human patients, cellular and animal models, carrying WDR45 mutations and their homologs. Autophagy researchers found an opportunity to explore the defective function of autophagy mechanisms associated with WDR45 mutations, which underlie neuronal dysfunction and early death. Importantly, BPAN is one of the few human monogenic neurological diseases targeting a regulator of autophagy, which raises the possibility that it is a relevant model to directly assess the roles of autophagy in neurodegeneration and to develop autophagy restorative therapeutic strategies for more common disorders., PAN research was supported by “Autour du BPAN”, “BPAN France” JORISS, Fondation Groupama grants to BM, MC, SA and LW. MM, AP, BM and LW were supported by a grant from the Million Dollar Bike Ride program (MDBR-21-123-BPAN and MDBR-23-015-NBIABPAN). RI and BM were supported by Marie Skłodowska-Curie Actions (NeuroDiDro - 101067877 - DLV-101067877). RE was supported by grant number PID2021-127355OB-I00 (MCIN/AEI/10.13039/501100011033/FEDER). SJH was supported by the NBIA Disorders Association, Hoffungsbaum e.V., AISNAF, and Isabel's Chance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of a novel mechanism for regulation of the early autophagy machinery assembly by PKA

  • Bueno Arribas, M.
  • Vincent, Olivier
The E3-like complex Atg12-Atg5-Atg16, which promotes Atg8 lipidation, is recruited to the autophagosomal membrane through the interaction of Atg16 with the PROPPIN/WIPI protein Atg21, as well as by the binding of Atg12 to Atg17, the scaffold protein of the Atg1 kinase complex in yeast. In order to gain insights into the molecular basis of Atg12-Atg17 interaction, we performed reverse two-hybrid screens to identify key-binding residues in both proteins and, based on these data, model the structure of this protein complex. Strikingly, we found that the Atg17 binding site in Atg12 overlaps with a PKA phosphorylation site and that PKA phosphorylation of Atg12 prevents Atg17 binding, revealing a new regulatory mechanism by which PKA regulates the assembly of the autophagy machinery., Our research was funded by grants [PGC2018–093604-B-I00] (MCIU/AEI/FEDER, UE)and [PID2021-127355OB-I00] (MICIU/AEI/10.13039/501100011033/FEDER,UE). M.B. was also supported by a fellowship from the Spanish “Ministerio de Ciencia,Innovación y Universidades”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The PKA Signaling Pathway Regulates the Association of the Autophagy Initiation Complex With the Lipidation Machinery

  • Bueno Arribas, M.
  • Cruz-Cuevas, Celia
  • Monforte-Martinez, Beatriz
  • Navas, María-Angeles
  • Escalante, Ricardo
  • Vincent, Olivier
A key step in autophagy is the conjugation by the E3-like Atg12-Atg5-Atg16 complex of the ubiquitin-like protein Atg8 to phosphatidylethanolamine on the autophagosomal membrane, a process known as lipidation. Previous work in yeast showed that recruitment of the E3-like complex to the preautophagosomal structure is mediated by the interaction of Atg16 with the phosphatidylinositol 3-phosphate-binding protein Atg21, and by the association of Atg12 with the scaffold protein of the Atg1 kinase complex, Atg17. Here, we conducted a reverse two-hybrid screen to identify residues in Atg17 and Atg12 critical for Atg17-Atg12 binding, and used these data to generate a docking model of Atg12-Atg5-Atg16 with the Atg17 complex. In this model, a conserved alpha-helix in the N-terminal region of Atg12 binds to the convex side of crescent-shaped Atg17 and appears to form a four-helix bundle with the three helices of Atg17, similar to that described for the binding of Atg31 to Atg17. We further showed that, in agreement with previous work, Atg17-Atg12 and Atg21-Atg16 binding act cooperatively to mediate the recruitment of the E3-like complex, although our results show that alternative mechanisms are involved in this process. Finally, we found that phosphorylation of Atg12 by PKA prevents its interaction with Atg17, thus adding a new regulatory layer in the control of autophagy by the PKA signaling pathway., This work has been supported by grants PGC2018-093604-B-I00 (MCIU/AEI/FEDER, UE) and PID2021-127355OB-I00 (MICIU/AEI/10.13039/501100011033/FEDER,UE). M.B. has been supported by a fellowship from the Spanish “Ministerio de Ciencia, Innovación y Universidades” and C.C. has been supported by the Garantía Juvenil Program from Comunidad de Madrid., Peer reviewed